• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝细胞癌肝移植受者的选择标准]

[Selection criteria for liver transplantation recipients of hepatocellular carcinoma].

作者信息

Cao L P, Wu J

机构信息

Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Zhejiang University, Hangzhou 310003, China.

出版信息

Zhonghua Gan Zang Bing Za Zhi. 2018 Feb 20;26(2):84-87. doi: 10.3760/cma.j.issn.1007-3418.2018.02.002.

DOI:10.3760/cma.j.issn.1007-3418.2018.02.002
PMID:29804371
Abstract

Liver transplantation is by far the most thorough and effective treatment for liver cancer. However, there is still much controversy about how to select receptors in an effective and equitable manner under the shortage of liver donor. The "Milan Standard" is the most widely used screening standard for liver transplantation recipients in the world. In recent years, many patients with Trans Milan criteria (such as Hangzhou standard) can achieve transplant survival similar to that of Milan patients after transplantation. This article describes the research progress of liver transplantation recipients' selection criteria in hepatocellular carcinoma.

摘要

肝移植是目前治疗肝癌最彻底、最有效的方法。然而,在肝供体短缺的情况下,如何以有效且公平的方式选择受体仍存在诸多争议。“米兰标准”是目前世界上应用最广泛的肝移植受者筛选标准。近年来,许多不符合米兰标准(如杭州标准)的患者在移植后也能获得与符合米兰标准患者相似的移植存活率。本文阐述了肝细胞癌肝移植受者选择标准的研究进展。

相似文献

1
[Selection criteria for liver transplantation recipients of hepatocellular carcinoma].[肝细胞癌肝移植受者的选择标准]
Zhonghua Gan Zang Bing Za Zhi. 2018 Feb 20;26(2):84-87. doi: 10.3760/cma.j.issn.1007-3418.2018.02.002.
2
Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio.在不做任何牺牲的情况下扩展米兰标准:杭州标准与移植前血小板与淋巴细胞比值的联合应用
BMC Cancer. 2017 Jan 5;17(1):14. doi: 10.1186/s12885-016-3028-0.
3
UCSF criteria by pre-transplant radiologic study can not assure similar post-transplant results of hepatocellular carcinoma within Milan criteria.移植前影像学检查的UCSF标准无法确保米兰标准内肝细胞癌的移植后结果相似。
Hepatogastroenterology. 2010 Jul-Aug;57(101):819-25.
4
Comparison of survival and tumor recurrence rates in patients undergoing liver transplantation for hepatitis B-related hepatocellular carcinoma using Milan, Shanghai Fudan and Hangzhou criteria.比较米兰标准、复旦上海标准和杭州标准用于乙肝相关肝细胞癌肝移植患者的生存率和肿瘤复发率。
J Dig Dis. 2013 Oct;14(10):552-8. doi: 10.1111/1751-2980.12083.
5
Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany.在德国,对于肝癌肝移植术后长期生存的预测,杭州标准比米兰标准更为准确。
Langenbecks Arch Surg. 2018 Aug;403(5):643-654. doi: 10.1007/s00423-018-1696-8. Epub 2018 Aug 17.
6
Liver transplantation for hepatocellular carcinoma beyond the Milan criteria.针对超出米兰标准的肝细胞癌进行肝移植
Gut. 2016 Jun;65(6):1035-41. doi: 10.1136/gutjnl-2014-308513. Epub 2015 Mar 24.
7
Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions.扩大肝移植米兰标准在肝癌治疗中的应用:未来的方向。
World J Gastroenterol. 2018 Aug 28;24(32):3626-3636. doi: 10.3748/wjg.v24.i32.3626.
8
[Value of liver transplantation in hepatocellular carcinoma treatment].[肝移植在肝细胞癌治疗中的价值]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug;30(4):366-70.
9
Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.米兰标准以外的肝细胞癌患者的肝切除与肝移植
Ann Surg. 2016 Oct;264(4):650-8. doi: 10.1097/SLA.0000000000001866.
10
How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?如何在肝细胞癌患者中决定是否进行肝移植:肿瘤大小和数量,还是 TACE 治疗的反应?
J Hepatol. 2013 Aug;59(2):279-84. doi: 10.1016/j.jhep.2013.04.006. Epub 2013 Apr 12.